Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development
- PMID: 32365191
- PMCID: PMC7239154
- DOI: 10.1093/infdis/jiaa234
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development
Comment in
-
Immunosenescence and Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.J Infect Dis. 2020 Nov 13;222(12):2114. doi: 10.1093/infdis/jiaa564. J Infect Dis. 2020. PMID: 32887991 Free PMC article. No abstract available.
